Understand the source comparison
Comparison with Other Metabolic Peptides
AOD-9604 differs mechanistically from growth hormone secretagogues such as GHRP-6, hexarelin, and ipamorelin, which act centrally to stimulate endogenous growth hormone release with consequent rises in IGF-1, lipolysis, and protein synthesis. Where secretagogu
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- AOD-9604 differs mechanistically from growth hormone secretagogues such as GHRP-6, hexarelin, and ipamorelin, which act centrally to stimulate endogenous growth hormone release with consequent rises in IGF-1, lipolysis, and protein synthesis. Where secretagogues amplify the entire somatotropic axis, AOD-9604 isolates a single downstream effect (lipolysis) while leaving central endocrine architecture undisturbed. This distinction has implications for the design of comparative metabolic research protocols.